Global, Regional, and National Epidemiology of Idiopathic Childhood Epilepsy from 1990 to 2021
Neuroepidemiology · 2025
DOI: 10.1159/000545830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, 2025. Verfasst von Yifeng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology II, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical Universit…. Hauptthemen laut MEDLINE: Epilepsy, Global Health. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Idiopathic childhood epilepsy is a major global health challenge with severe outcomes such as depression, intellectual disability, and increased suicide risk. It is vital to understand epidemiological trends and risk factors to effectively address the condition’s burden.
Methods
This cross-sectional study utilized data from the Global Burden of Disease (GBD) study, covering 204 countries from 1990 to 2021, focusing on children aged 0–14 years with idiopathic epilepsy. We analyzed trends in incidence, mortality, and disability-adjusted life years (DALYs), examining variations across different demographics and Sociodemographic Indices (SDI).
Results
In 2021, there were approximately 1.23 million cases of childhood idiopathic epilepsy worldwide, marking a 26.34% increase from 1990. During the same period, deaths attributed to idiopathic epilepsy decreased from 25,768 to 18,171. The global incidence rate rose from 55.85 to 61.00 per 100,000 population, while the mortality rate declined from 1.48 to 0.90 per 100,000. The lowest SDI regions recorded the highest mortality rate in 2021 (1.46 per 100,000). Regionally, Southern Latin America saw the largest increase in incidence (EAPC, 0.49), and Eastern Europe observed the most significant mortality decrease (EAPC, −4.65). Ecuador reported the highest incidence rate, Tajikistan the highest mortality, and Zambia the highest DALYs in 2021.
Conclusions
The global incidence of idiopathic childhood epilepsy continues to rise, presenting an ongoing public health challenge. Although there is a global decline in DALYs and mortality rates, the absolute number of affected individuals remains high, particularly in lower SDI regions. This study underlines the need for enhanced understanding and targeted interventions to manage and prevent idiopathic epilepsy effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology II, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Emergency Department, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Department of Neurology II, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, China, wangyq6@mail3.sysu.edu.cn.
Zitieren
APA
Zhang, Y., Hou, S., Li, J., Geng, J., Xia, Y., & Wang, Y. (2025). Global, Regional, and National Epidemiology of Idiopathic Childhood Epilepsy from 1990 to 2021. Neuroepidemiology. https://doi.org/10.1159/000545830
Vancouver
Zhang Y, Hou S, Li J, Geng J, Xia Y, Wang Y. Global, Regional, and National Epidemiology of Idiopathic Childhood Epilepsy from 1990 to 2021. Neuroepidemiology. 2025. doi:10.1159/000545830
BibTeX
@article{Zhang2025,
author = {Zhang, Yifeng and Hou, Shuai and Li, Jian and Geng, Jianhong and Xia, Yulei and Wang, Yanqiang},
title = {Global, Regional, and National Epidemiology of Idiopathic Childhood Epilepsy from 1990 to 2021},
journal = {Neuroepidemiology},
year = {2025},
doi = {10.1159/000545830}
}
EUVIMED